Activation and regulation of pathogen sensor RIG-I

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 513-523

  Patel, Jenish R ^a   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral response; Innate immunity; RIG I like receptors; Type I interferon; Virus

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; RETINOIC ACID INDUCIBLE PROTEIN I; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN;

AUTOREGULATION; BACTERIAL INFECTION; CONFORMATIONAL TRANSITION; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; ENZYME ACTIVATION; IMMUNOLOGY; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DEAD-BOX RNA HELICASES; ENZYME ACTIVATION; HUMANS; IMMUNITY, INNATE; INTERFERONS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 84908279593     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.08.005     Document Type: Review

References (137)

1. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
2. Liu S.-Y., Sanchez D.J., Cheng G. New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 2011, 23:57-64.
3. Shatkin A.J., Manley J.L. The ends of the affair: capping and polyadenylation. Nat Struct Biol 2000, 7:838-842.
4. Daffis S., Szretter K.J., Schriewer J., Li J., Youn S., Errett J., et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010, 468:452-456.
5. Züst R., Cervantes-Barragan L., Habjan M., Maier R., Neuman B.W., Ziebuhr J., et al. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 2011, 12:137-143.
6. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005, 202:1575-1585.
7. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
8. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004, 101:5598-5603.
9. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169:6668-6672.
10. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003, 4:161-167.
11. Du X., Poltorak A., Wei Y., Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000, 11:362-371.
12. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4537.
13. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
14. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194:863-869.
15. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
16. Hidmark A., von Saint Paul A., Dalpke A.H. Cutting edge: TLR13 is a receptor for bacterial RNA. J Immunol 2012, 189:2717-2721.
17. Oldenburg M., Krüger A., Ferstl R., Kaufmann A., Nees G., Sigmund A., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012, 337:1111-1115.
18. Li X-D., Chen Z.J. Sequence specific detection of bacterial 23S ribosomal RNA by TLR13. Elife 2012, 1:e00102.
19. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
20. Bürckstümmer T., Baumann C., Blüml S., Dixit E., Dürnberger G., Jahn H., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009, 10:266-272.
21. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
22. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
23. Srinivasula S.M., Poyet J.-L., Razmara M., Datta P., Zhang Z., Alnemri E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002, 277:21119-21122.
24. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
25. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
26. Unterholzner L., Keating S.E., Baran M., Horan K.a., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
27. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012, 1:e00047.
28. Yang P., An H., Liu X., Wen M., Zheng Y., Rui Y., et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 2010, 11:487-494.
29. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
30. Kanneganti T-D., Body-Malapel M., Amer A., Park J-H., Whitfield J., Franchi L., et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006, 281:36560-36568.
31. Mitoma H., Hanabuchi S., Kim T., Bao M., Zhang Z., Sugimoto N., et al. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. Immunity 2013, 39:123-135.
32. Zhang Z., Kim T., Bao M., Facchinetti V., Jung S.Y., Ghaffari A.A., et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011, 34:866-878.
33. Zhang Z., Yuan B., Lu N., Facchinetti V., Liu Y.-J. DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. J Immunol 2011, 187:4501-4508.
34. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175:2851-2858.
35. Sun Y.W. RIG-I, a human homolog gene of RNA helicase, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell 1997, [Ph.D. thesis], Shanghai Second Med Univ., Shanghai.
36. Imaizumi T., Aratani S., Nakajima T., Carlson M., Matsumiya T., Tanji K., et al. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem Biophys Res Commun 2002, 292:274-279.
37. Cui X.-F., Imaizumi T., Yoshida H., Borden E.C., Satoh K. Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells. Biochem Cell Biol 2004, 82:401-405.
38. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
39. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
40. Pichlmair A., Schulz O., Tan C.P., Näslund T.I., Liljeström P., Weber F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
41. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
42. Foy E., Li K., Sumpter R., Loo Y-M., Johnson C.L., Wang C., et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 2005, 102:2986-2991.
43. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
44. Loo Y-M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82:335-345.
45. Shingai M., Ebihara T., Begum N.A., Kato A., Honma T., Matsumoto K., et al. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 2007, 179:6123-6133.
46. Samanta M., Iwakiri D., Kanda T., Imaizumi T., Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006, 25:4207-4214.
47. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
48. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
49. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106:12067-12072.
50. Binder M., Eberle F., Seitz S., Mücke N., Hüber C.M., Kiani N., et al. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 2011, 286:27278-27287.
51. Patel JR, Jain A, Chou Y, Baum A, Ha T, Garcia-Sastre A. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO rep 2013, advance on.
52. Pichlmair A., Schulz O., Tan C-P., Rehwinkel J., Kato H., Takeuchi O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
53. Baum A., Sachidanandam R., García-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
54. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
55. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
56. Malathi K., Saito T., Crochet N., Barton D.J., Gale M., Silverman R.H. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. RNA 2010, 16:2108-2119.
57. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
58. Jiang F., Ramanathan A., Miller M.T., Tang G.-Q., Gale M., Patel S.S., et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 1-7.
59. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
60. Chiu Y.-H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
61. Jehl S.P., Nogueira C.V., Zhang X., Starnbach M.N. IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I. PLoS Pathog 2012, 8:e1002809.
62. Abdullah Z., Schlee M., Roth S., Mraheil M.A., Barchet W., Böttcher J., et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J 2012, 31:4153-4164.
63. Hagmann C.A., Herzner A.M., Abdullah Z., Zillinger T., Jakobs C., Schuberth C., et al. RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS One 2013, 8:e62872.
64. Schmolke M., Patel J.R., de Castro E., Sánchez-Aparicio M.T., Uccellini M.B., Miller J.C., et al. RIG-I detects mRNA of intracellular Salmonella enterica Serovar Typhimurium during bacterial infection. MBio 2014, 5.
65. Feng Q., Hato S.V., Langereis M.A., Zoll J., Virgen-Slane R., Peisley A., et al. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep 2012, 2:1187-1196.
66. Berke I.C., Modis Y. MDA5 cooperatively forms dimers and ATP sensitive filaments upon binding to dsRNA. EMBO J 2012, 31:1714-1726.
67. Peisley A., Lin C., Wu B., Orme-Johnson M., Liu M., Walz T., et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci U S A 2011, 108:21010-21015.
68. Runge S., Sparrer K.M.J., Lässig C., Hembach K., Baum A., García-Sastre A., et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 2014, 10:e1004081.
69. Triantafilou K., Vakakis E., Kar S., Richer E., Evans G.L., Triantafilou M. Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses. J Cell Sci 2012, 125:4761-4769.
70. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 2005, 175:5260-5268.
71. Saito T., Hirai R., Loo Y-M., Owen D., Johnson C.L., Sinha S.C., et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 2007, 104:582-587.
72. Komuro A., Horvath C.M. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J Virol 2006, 80:12332-12342.
73. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010, 107:1512-1517.
74. Cui S., Eisenächer K., Kirchhofer A., Brzózka K., Lammens A., Lammens K., et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 2008, 29:169-179.
75. Lu C., Ranjith-Kumar C.T., Hao L., Kao C.C., Li P. Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5' triphosphate. Nucleic Acids Res 2010, 39:1-11.
76. Wang Y., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 2010, 17:781-787.
77. Fairman-Williams M.E., Guenther U.-P., Jankowsky E. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol 2010, 20:313-324.
78. Kowalinski E., Lunardi T., Mccarthy A.A., Louber J., Brunel J., Grigorov B., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
79. Luo D., Ding S.C., Vela A., Kohlway A., Lindenbach B.D., Pyle A.M. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422.
80. Ferrage F., Dutta K., Nistal-Villán E., Patel J.R., Sánchez-Aparicio M.T., De Ioannes P., et al. Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. Structure 2012, 20:2048-2061.
81. Kohlway A., Luo D., Rawling D.C., Ding S.C., Pyle A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 2013, 14:772-779.
82. Kolakofsky D., Kowalinski E., Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
83. Gack M.U., Shin Y.C., Joo C-H.H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
84. Oshiumi H., Matsumoto M., Hatakeyama S., Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 2009, 284:807-817.
85. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
86. Jiang X., Kinch L.N., Brautigam C.A., Chen X., Du F., Grishin N.V., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
87. Myong S., Cui S., Cornish P.V., Kirchhofer A., Gack M.U., Jung J.U., et al. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323:1070-1074.
88. Peisley A., Wu B., Yao H., Walz T., Hur S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 2013, 51:573-583.
89. Peisley A., Wu B., Xu H., Chen Z.J., Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
90. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
91. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6:981-988.
92. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
93. Xu L.-G., Wang Y.-Y., Han K.-J., Li L.-Y., Zhai Z., Shu H-B. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 2005, 19:727-740.
94. Hou F., Sun L., Zheng H., Skaug B., Jiang Q-X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
95. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., Morimoto S., et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010, 6:e1001012.
96. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.-X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
97. Xu H., He X., Zheng H., Huang L.J., Hou F., Yu Z., et al. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife 2014, 3:e01489.
98. Cai X., Chen J., Xu H., Liu S., Jiang Q.-X., Halfmann R., et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014, 156:1207-1222.
99. Hayden M.S., Ghosh S. NF-κB in immunobiology. Cell Res 2011, 21:223-244.
100. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 2002, 64:985-992.
101. Sharma S., tenOever B.R., Grandvaux N., Zhou G.-P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
102. Panne D. The enhanceosome. Curr Opin Struct Biol 2008, 18:236-242.
103. Gack M.U., Nistal-Villán E., Inn K.-S., García-Sastre A., Jung J.U. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 2010, 84:3220-3229.
104. Nistal-Villán E., Gack M.U., Martínez-Delgado G., Maharaj N.P., Inn K.-S., Yang H., et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J Biol Chem 2010, 285:20252-20261.
105. Maharaj N.P., Wies E., Stoll A., Gack M.U. Conventional protein kinase C-α (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction. J Virol 2012, 86:1358-1371.
106. Wies E., Wang M.K., Maharaj N.P., Chen K., Zhou S., Finberg R.W., et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 2013, 38:437-449.
107. Sun Z., Ren H., Liu Y., Teeling J.L., Gu J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol 2011, 85:1036-1047.
108. Miyashita M., Oshiumi H., Matsumoto M., Seya T. DDX60, a DExD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol Cell Biol 2011, 31:3802-3819.
109. Friedman C.S., O'Donnell M.A., Legarda-Addison D., Ng A., Cárdenas W.B., Yount J.S., et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008, 9:930-936.
110. Cui J., Song Y., Li Y., Zhu Q., Tan P., Qin Y., et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res 2013, 24:400-416.
111. Fan Y., Mao R., Yu Y., Liu S., Shi Z., Cheng J., et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 2014, 211:313-328.
112. Inn K.-S., Gack M.U., Tokunaga F., Shi M., Wong L.-Y., Iwai K., et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol Cell 2011, 41:354-365.
113. Kok K.-H., Lui P.-Y., Ng M.-H.J., Siu K.-L., Au S.W.N., Jin D.-Y. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011, 9:299-309.
114. Hayakawa S., Shiratori S., Yamato H., Kameyama T., Kitatsuji C., Kashigi F., et al. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 2011, 12:37-44.
115. Liu H.M., Loo Y.-M., Horner S.M., Zornetzer G.A., Katze M.G., Gale M. The Mitochondrial Targeting Chaperone 14-3-3e regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 2012, 11:528-537.
116. Wang Y., Tong X., Li G., Li J., Deng M., Ye X. Ankrd17 positively regulates RIG-I-like receptor (RLR)-mediated immune signaling. Eur J Immunol 2012, 42:1304-1315.
117. Jounai N., Takeshita F., Kobiyama K., Sawano A., Miyawaki A., Xin K.-Q., et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A 2007, 104:14050-14055.
118. Arimoto K., Takahashi H., Hishiki T., Konishi H., Fujita T., Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A 2007, 104:7500-7505.
119. Das A., Dinh P.X., Panda D., Pattnaik A.K. Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J Virol 2014, 88:3103-3113.
120. Wang L., Zhao W., Zhang M., Wang P., Zhao K., Zhao X., et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol 2013, 87:4507-4515.
121. Matsumiya T., Imaizumi T., Yoshida H., Satoh K., Topham M.K., Stafforini D.M. The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. J Immunol 2009, 182:2717-2725.
122. Guo Z., Chen L., Zeng H., Gomez J.A., Plowden J., Fujita T., et al. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 2007, 36:263-269.
123. Mibayashi M., Martínez-Sobrido L., Loo Y.-M., Cárdenas W.B., Gale M., García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007, 81:514-524.
124. Opitz B., Rejaibi A., Dauber B., Eckhard J., Vinzing M., Schmeck B., et al. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 2007, 9:930-938.
125. Cárdenas W.B., Loo Y.-M., Gale M., Hartman A.L., Kimberlin C.R., Martínez-Sobrido L., et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 2006, 80:5168-5178.
126. Gack M.U., Albrecht R.A., Urano T., Inn K.-S., Huang I.-C., Carnero E., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5:439-449.
127. Rajsbaum R., Albrecht R.A., Wang M.K., Maharaj N.P., Versteeg G.A., Nistal-Villán E., et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 2012, 8:e1003059.
128. Habjan M., Andersson I., Klingström J., Schümann M., Martin A., Zimmermann P., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3:e2032.
129. Gori-Savellini G., Valentini M., Cusi M.G. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013, 87:6660-6667.
130. Santiago F.W., Covaleda L.M., Sanchez-Aparicio M.T., Silvas J.A., Diaz-Vizarreta A.C., Patel J.R., et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of Type I interferon responses. J Virol 2014, 88:4572-4585.
131. Fan L., Briese T., Lipkin W.I. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010, 84:1785-1791.
132. Ling Z., Tran K.C., Teng M.N. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 2009, 83:3734-3742.
133. Li X.-D., Sun L., Seth R.B., Pineda G., Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102:17717-17722.
134. Nasirudeen A.M.A., Wong H.H., Thien P., Xu S., Lam K.-P., Liu D.X. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 2011, 5:e926.
135. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 2008, 82:609-616.
136. Plumet S., Herschke F., Bourhis J.-M., Valentin H., Longhi S., Gerlier D. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2007, 2:e279.
137. Uzri D., Greenberg H.B. Characterization of rotavirus RNAs that activate innate immune signaling through the RIG-I-like receptors. PLoS One 2013, 8:e69825.